T2 gains on approval of fungal tests

T2 Biosystems Inc. (NASDAQ:TTOO) jumped $1.62 (10%) to $18.55 on Tuesday after FDA approved the company's T2Candida Panel and T2Dx instrument to detect Candida pathogens that lead to sepsis. ...